Back to Search
EDWINA VERNER, MD
MD
Pediatric Adolescent Medicine Physician
NPI: 1457303919Individual
Specialties, Licenses & Credentials
Pediatric Adolescent Medicine PhysicianPrimary
Pediatrics — Adolescent Medicine
Code: 2080A0000X
25MA03802100(NJ)
Research & Publications (14)
Isoform-specific histone deacetylase inhibitors: the next step?
PMID 19289255·Cancer Lett·2009
6-review
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas.
PMID 18256683·Leukemia·2008
8-other
CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo.
PMID 16891455·Mol Cancer Ther·2006
7-preclinical
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.
PMID 16731764·Mol Cancer Ther·2006
7-preclinical
Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
PMID 16257204·Bioorg Med Chem Lett·2006
8-other
Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).
PMID 15522303·J Mol Biol·2004
4-observational
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
PMID 15242608·Structure·2004
8-other
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
PMID 12742021·J Mol Biol·2003
7-preclinical
2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.
PMID 12113832·Bioorg Med Chem Lett·2002
8-other
Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.
PMID 11731301·Chem Biol·2001
7-preclinical
Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator.
PMID 11689072·J Med Chem·2001
7-preclinical
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa.
PMID 11495587·J Med Chem·2001
8-other
Development of potent and selective factor Xa inhibitors.
PMID 11459634·Bioorg Med Chem Lett·2001
8-other
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
PMID 11292354·J Mol Biol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 86 S HARRISON ST
EAST ORANGE, NJ 07018 - Phone
- (973) 414-1886
Quick Facts
- NPI
- 1457303919
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile